Description: Join us for an insightful session on best practices in setting assumptions and margins for Life and Annuity Products. This session will explore traditional best practices outlined by the ASOPs as well as their application in the context of emerging trends and risks in 2024, such as predictive analytics and AI. The session will also cover evolving trends in assumption governance, as corporate ERM areas become increasingly involved in the assumption setting process. Learning objectives include refreshing and enhancing knowledge of existing ASOPs, as well as understanding strategies for emerging risks that the ASOPs do not yet cover.

Description: EHRs are a source of digital health data that present both an opportunity and a challenge for insurers. These rapidly maturing data sources contain valuable insights and can create a faster, better applicant experience, but the costs can quickly add up. Listen to panelists discuss various use cases for EHRs, their protective value in relation to traditional underwriting approaches, and other considerations for expanding EHR use. We will take a look at how using EHRs could promote a smart ordering approach allowing us to be quicker and more cost effective, all while understanding the impact to mortality.

Description: This session will cover the treatment of various forms of reinsurance under Valuation Manual-20 (VM-20). Speakers will discuss the implications of various types of reinsurance agreements on the calculation of principle-based reserves (PBR). This will include coinsurance and modified coinsurance, guaranteed and non-guaranteed yearly renewable term (YRT), as well as financial reinsurance.

Description: LDTI requires that reinsurance recoverables be recognized in a manner consistent with the liabilities of underlying direct contracts. Consider implications of multiple ceded reinsurance contracts (e.g., coinsurance and YRT on the same business) and how this impacts the calculation of the net premium ratio (NPR) and other related approximations. Explore different options when only some of the policies within a cohort are reinsured. Multiple interpretations of the components of the NPR formula exist. Two main approaches will be presented-standalone and integrated approach. Other considerations to be discussed include implications of closed-block reinsurance transactions at transition and subsequent to transition, contra-DAC, market risk benefits. Finally, explore the short-duration YRT approximation (1/2 Cx) compared to the long-duration calculation.

Description: Delves into the impact of rising interest rates on annuity product management, with a focus on the challenges of disintermediation and implications to hedging. Learn about in-force management actions, best practices for managing annuities in a changing environment and associated risks. Explore how companies are revising their hedging strategies to adapt to shifting market conditions and regulatory framework changes. Gain a comprehensive understanding of the relation between rising interest rates and disintermediation, its financial and business impacts, and strategies for managing business and setting assumptions during periods of high disintermediation. Come away with practical strategies for optimizing returns, minimizing risks, and navigating the challenges and opportunities associated with annuity product management in the current interest rate environment.

Description: LDTI's roll forward disclosure requirements include line items for the impact of actual variances from expected experience (A/E) for both net premiums and benefits. These aggregate A/E amounts provide some insight into how actual experience is emerging relative to expectations, but they do not provide insight into either the drivers of the deviations or their significance.

Description: Gain an overview of the requirements for the new asset adequacy Actuarial Guideline 53 (AG53) guideline for complex assets. You will discover helpful insights and considerations for multi-scenario testing and sensitivity testing as well as approaches to developing attribution analyses for complex assets. You will also receive insights from any published regulatory materials that help describe what worked well and what needs improvement based on the initial AG 53 submissions from year-end 2022.

Description: As companies have reported their latest financials for 2023, LDTI is in its full swing for the public companies. Under US GAAP reinsurance accounting methods can be daunting. Add onto this legacy practices related to reinsurance reporting and this may lead to significant unwinding and implementation efforts. This session will discuss industry practices commonly applied to US GAAP reinsurance reported balances such that LDTI adopters can gather deeper insights into the LDTI impact. Specifically, the session will explain the two most popular methods to value reinsurance under LDTI, methods applying a direct measurement of the reinsurance net cost and a method that recognizes ceded asset balances and a cost of reinsurance (“CoRe”). The session will present simplified direct and ceded models to demonstrate how the actuarial balances under LDTI impact GAAP book profits for different underlying products and reinsurance types.

Description: This session will examine bias from a social science perspective. It will discuss the three types of systemic biases using the National Institute of Standards and Technology (NIST) model. The NIST model details the three types as historical bias, societal bias, and institutionalbias. The session will also provide several examples of each type to provide a framework for identifying the social structure of bias.

Description: Life insurance with LTC features is exciting business to produce, but the complex for a valuation actuary at year-end. This session will discuss setting morbidity and policyholder behavior assumptions for principles-based reserving and cash flow testing more generally. We will review considerations for GAAP reserving for hybrid products. We will highlight the interaction of assumptions whose risks offset (mortality, morbidity, lapse, and more) and how the valuation actuary may think of these in sensitivity testing and setting prudent estimates. Panelists will draw from the 2022 Academy of Actuaries Combination Product Valuation Practice Note.Finally, we will discuss reserve assumption setting in light of public-private LTC legislation (e.g. Washington Cares), which inspired sales of hybrid life and LTC products in the individual and worksite markets.